2022
DOI: 10.1021/acs.jproteome.2c00323
|View full text |Cite
|
Sign up to set email alerts
|

Quantifying In Situ Structural Stabilities of Human Blood Plasma Proteins Using a Novel Iodination Protein Stability Assay

Abstract: Many of the diseases that plague society today are driven by a loss of protein quality. One method to quantify protein quality is to measure the protein folding stability (PFS). Here, we present a novel mass spectrometry (MS)-based approach for PFS measurement, iodination protein stability assay (IPSA). IPSA quantifies the PFS by tracking the surface-accessibility differences of tyrosine, histidine, methionine, and cysteine under denaturing conditions. Relative to current methods, IPSA increases protein covera… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
9
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
4

Relationship

2
2

Authors

Journals

citations
Cited by 4 publications
(9 citation statements)
references
References 106 publications
(137 reference statements)
0
9
0
Order By: Relevance
“…Included with C Half are instructions for installation and operation as well as a series of tutorial videos at . C Half requires an experimental design common to chemical or thermal denaturing experiments and that MS data be preprocessed through an MSMS identification and quantification software package such as Protein Prospector, Comet, Mascot, MaxQuant, or PEAKS Studio Figure shows the general workflow of C Half from pre-C Half processing (Figure A), C Half Initialization (Figure B), curve fitting (Figure C), quality control tools (Figure D), combined site stability (Figure E), and data visualization (Figure F).…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…Included with C Half are instructions for installation and operation as well as a series of tutorial videos at . C Half requires an experimental design common to chemical or thermal denaturing experiments and that MS data be preprocessed through an MSMS identification and quantification software package such as Protein Prospector, Comet, Mascot, MaxQuant, or PEAKS Studio Figure shows the general workflow of C Half from pre-C Half processing (Figure A), C Half Initialization (Figure B), curve fitting (Figure C), quality control tools (Figure D), combined site stability (Figure E), and data visualization (Figure F).…”
Section: Methodsmentioning
confidence: 99%
“…C Half uses peptide abundances to calculate PFS by first normalizing them and plotting them against their denaturant concentration/temperature values (Figure C). These points are used to fit a sigmoid curve using the curve_fit method from the Python SciPy module and a fitting equation (eq ) that has been used almost universally across different studies of PFS. y = B + A B 1 + e false( prefix− 1 false) false( C 1 2 x false) / b The parameters for the equation were normalized peptide signal intensity in each fraction ( y ), final denaturant concentration or temperature of each fraction ( x ), pretransition baseline ( A ), post-transition baseline ( B ), denature midpoint ( C 1/2 or T m ), and the slope of transition ( b ).…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…To increase the throughput, one-point approaches of SPROX and pulse proteolysis have been developed by pooling the ligand-treated and vehicle-treated samples across all the denaturing conditions following chemical modification or proteolysis, providing powerful tools for high-throughput PECI mapping. More recently, John C. Price group introduced IPSA to monitor the surface-accessibility differences of tyrosine, histidine, methionine, and cysteine under denaturing conditions and a user-friendly data processing tool of C Half to calculate protein folding stability changes from chemical denature folding stability assays, demonstrating increased sensitivity compared with SPROX. , …”
Section: Overview Of the Methods For Peci Mappingmentioning
confidence: 99%
“…To better understand RA pathology and changes in HSA stability, future RA studies should look for potential binding partners by extracting lipids and small molecules from purified serum HSA. Other directions to explore the mechanisms that increase HSA stability are: (1) Using more specific surface modifications or chemical crosslinking reagents to carry out indepth surface probing of HSA, collect specific information about HSA binding partners and coordination changes [93,94], and (2) comparing HSA and CRP protein binding partners in RA and non-RA patients using immunoaffinity purification together with mass spectrometry to understand how a change in CRP concentration could be contributing to HSA interactor changes. Future research into HSA and other related proteins will continue to enhance our understanding of RA-specific pathology and give insights into the development of, and potential treatments for, RA.…”
Section: Plos Onementioning
confidence: 99%